Module 39

References chapter 48 (10 key references can also be found in the Textbook directly)

10 Key references

Doherty, M., et al., A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of
ibuprofen/paracetamol in community-derived people with knee pain. Annals of the rheumatic diseases, 2011.
70(9): p. 1534-41.
Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition:
therapeutic challenges and opportunities. J Clin Invest 2006;116:4–15.
Hess, A., et al., Blockade of TNF-alpha rapidly inhibits pain responses in the central nervous system.
Proceedings of the National Academy of Sciences of the United States of America, 2011. 108(9): p. 3731-6.
Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-
steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.
BMJ 2006;332:1302–8.
Lin J, Zhang W, Jones A, et al. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of
osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004;329:324.
Marinus, J., et al., Clinical features and pathophysiology of complex regional pain syndrome. Lancet neurology,
2011. 10(7): p. 637-48.
Schaible, H.G., A. Del Rosso, and M. Matucci-Cerinic, Neurogenic aspects of inflammation. Rheumatic
diseases clinics of North America, 2005. 31(1): p. 77-101, ix.
Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann
Intern Med 2004;140:441–51.
Wise, T.N., D.A. Fishbain, and V. Holder-Perkins, Painful physical symptoms in depression: a clinical
challenge. Pain Med, 2007. 8 Suppl 2: p. S75-82.
Zeilhofer HU, Brune K. Analgesic strategies beyond the inhibition of cyclooxygenases. Trends Pharmacol Sci
2006;27:467–74.
References
1.
Pain terms: a list with definitions and notes on usage. Recommended by the IASP
Subcommittee on Taxonomy. Pain, 1979. 6(3): p. 249.
Melzack, R., From the gate to the neuromatrix. Pain, 1999. S6: p. S121-S126.
Levine, J.D. and N. Alessandri-Haber, TRP channels: targets for the relief of pain. Biochim
Biophys Acta, 2007. 1772(8): p. 989-1003.
Waldmann, R., et al., A proton-gated cation channel involved in acid-sensing. Nature, 1997.
386(6621): p. 173-7.
Cook, S.P. and E.W. McCleskey, Desensitization, recovery and Ca(2+)-dependent modulation
of ATP-gated P2X receptors in nociceptors. Neuropharmacology, 1997. 36(9): p. 1303-8.
Melzack, R. and P.D. Wall, Pain mechanisms: a new theory. Science, 1965. 150(699): p. 971-
9.
Willis, W.D. and K.N. Westlund, Neuroanatomy of the pain system and of the pathways that
modulate pain. J Clin Neurophysiol, 1997. 14(1): p. 2-31.
Hunt, S.P. and P.W. Mantyh, The molecular dynamics of pain control. Nat Rev Neurosci,
2001. 2(2): p. 83-91.
Tracey, I., Imaging pain. Br J Anaesth, 2008. 101(1): p. 32-9.
Apkarian, A.V., et al., Human brain mechanisms of pain perception and regulation in health
and disease. Eur J Pain, 2005. 9(4): p. 463-84.
Woolf, C.J., Pain: moving from symptom control toward mechanism-specific pharmacologic
management. Ann Intern Med, 2004. 140(6): p. 441-51.
Melzack, R., Phantom limbs and the concept of a neuromatrix. Trends Neurosci, 1990. 13(3):
p. 88-92.
Zeilhofer, H.U. and K. Brune, Analgesic strategies beyond the inhibition of cyclooxygenases.
Trends Pharmacol Sci, 2006. 27(9): p. 467-74.
Opree, A. and M. Kress, Involvement of the proinflammatory cytokines tumor necrosis factor-
alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on
heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci, 2000. 20(16): p.
6289-93.
Schaible, H.G., A. Del Rosso, and M. Matucci-Cerinic, Neurogenic aspects of inflammation.
Rheumatic diseases clinics of North America, 2005. 31(1): p. 77-101, ix.
Tracey, K.J., Reflex control of immunity. Nature reviews. Immunology, 2009. 9(6): p. 418-28.
Henriksen, G. and F. Willoch, Imaging of opioid receptors in the central nervous system.
Brain, 2008. 131(Pt 5): p. 1171-96.
Shortland, P. and C.J. Woolf, Chronic peripheral nerve section results in a rearrangement of
the central axonal arborizations of axotomized A beta primary afferent neurons in the rat
spinal cord. J Comp Neurol, 1993. 330(1): p. 65-82.
Hori, T., et al., Pain modulatory actions of cytokines and prostaglandin E2 in the brain. Ann N
Y Acad Sci, 1998. 840: p. 269-81.
Schafers, M. and L. Sorkin, Effect of cytokines on neuronal excitability. Neurosci Lett, 2008.
437(3): p. 188-93.
Hess, A., et al., Blockade of TNF-alpha rapidly inhibits pain responses in the central nervous
system. Proceedings of the National Academy of Sciences of the United States of America,
2011. 108(9): p. 3731-6.
Marinus, J., et al., Clinical features and pathophysiology of complex regional pain syndrome.
Lancet neurology, 2011. 10(7): p. 637-48.
Desmeules, J.A., et al., Neurophysiologic evidence for a central sensitization in patients with
fibromyalgia. Arthritis Rheum, 2003. 48(5): p. 1420-9.
Gracely, R.H., et al., Functional magnetic resonance imaging evidence of augmented pain
processing in fibromyalgia. Arthritis Rheum, 2002. 46(5): p. 1333-43.
Gallagher, R.M., P. Moore, and I. Chernoff, The reliability of depression diagnosis in chronic
low back pain. A pilot study. Gen Hosp Psychiatry, 1995. 17(6): p. 399-413.
Magni, G., et al., Chronic musculoskeletal pain and depressive symptoms in the general
population. An analysis of the 1st National Health and Nutrition Examination Survey data.
Pain, 1990. 43(3): p. 299-307.
Kroenke, K. and R.K. Price, Symptoms in the community. Prevalence, classification, and
psychiatric comorbidity. Arch Intern Med, 1993. 153(21): p. 2474-80.
Melzack, R. and J. Katz, Pain assessment in the adult patient. 5th ed. Wall and Melzack's Textbook of Pain, ed. S.B. McMahon and M. Koltzenburg. Vol. 1. 2006, London: Elsevier. 291-304. Dudgeon, D., R.F. Ranbertas, and S. Rosenthal, The short-form McGill Pain Questionnaire in
chronic cancer pain. Journal of Pain and Symptom Managment, 1993. 8: p. 191-195.
Dickens, C., et al., Depression in rheumatoid arthritis: a systematic review of the literature
with meta-analysis. Psychosom Med, 2002. 64(1): p. 52-60.
Waddell, G. and A.K. Burton, Concepts of rehabilitation for the management of low back pain.
Best Pract Res Clin Rheumatol, 2005. 19(4): p. 655-70.
Ware, J.E., et al., Conceptualisation and measurement of health for adults in the health insurance study1980, Santa Monica, California: Rand Corp. Stiefel, F.C., et al., INTERMED - an assessment and classification system for case complexity.
Spine, 1999. 24: p. 378-385.
Koch, N., et al., Identification of case complexity and increased health care utilization in
patients with rheumatoid arthritis. Arthritis Rheum, 2001. 45: p. 216-221.
Kelly, G.A., et al., The association between chronic low back pain and sleep: a systematic
review. The Clinical journal of pain, 2011. 27(2): p. 169-81.
Vane, J.R., Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like
drugs. Nat New Biol, 1971. 231(25): p. 232-5.
Brune, K. and H.U. Zeilhofer, Antipyretic analgesics: basic aspects. 5th ed. Wall and Melzack's Textbook of pain, ed. S.M. McMahon and M. Koltzenburg 2006, London: Elsevier. 459-470. Anderson, G.D., et al., Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation
and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J.Clin.Invest., 1996. 97: p.
2672-2679.
Grosser, T., S. Fries, and G.A. FitzGerald, Biological basis for the cardiovascular
consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest,
2006. 116(1): p. 4-15.
Kearney, P.M., et al., Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal
anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised
trials. Bmj, 2006. 332(7553): p. 1302-8.
Capone, M.L., et al., Human pharmacology of naproxen sodium. J Pharmacol Exp Ther, 2007.
322(2): p. 453-60.
Rahme, E. and H. Nedjar, Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs:
does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort
study. Rheumatology (Oxford), 2007. 46(3): p. 435-8.
Goldstein, J.L., et al., Video capsule endoscopy to prospectively assess small bowel injury with
celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol, 2005. 3(2): p.
133-41.
Charlot, M., et al., Proton pump inhibitor use and risk of adverse cardiovascular events in
aspirin treated patients with first time myocardial infarction: nationwide propensity score
matched study. BMJ, 2011. 342: p. d2690.
Graham, G.G. and K.F. Scott, Mechanism of action of paracetamol. Am J Ther, 2005. 12(1): p.
46-55.
Hinz, B., O. Cheremina, and K. Brune, Acetaminophen (paracetamol) is a selective
cyclooxygenase-2 inhibitor in man. Faseb J, 2008. 22(2): p. 383-90.
Brune, K., B. Hinz, and I. Otterness, Aspirin and acetaminophen: should they be available over
the counter? Current rheumatology reports, 2009. 11(1): p. 36-40.
Brune, K. and B. Hinz, Paracetamol, ibuprofen, or a combination of both drugs against knee
pain: an excellent new randomised clinical trial answers old questions and suggests new
therapeutic recommendations. Annals of the rheumatic diseases, 2011. 70(9): p. 1521-2.
Erdogan, F., et al., The diffusion of nimesulide gel into synovial fluid: a comparison between
administration routes. Int J Clin Pharmacol Ther, 2006. 44(6): p. 270-5.
Rainsford, K.D., W.F. Kean, and G.E. Ehrlich, Review of the pharmaceutical properties and
clinical effects of the topical NSAID formulation, diclofenac epolamine. Curr Med Res Opin,
2008. 24(10): p. 2967-92.
Mason, L., et al., Topical NSAIDs for chronic musculoskeletal pain: systematic review and
meta-analysis. BMC Musculoskelet Disord, 2004. 5: p. 28.
Lin, J., et al., Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of
osteoarthritis: meta-analysis of randomised controlled trials. Bmj, 2004. 329(7461): p. 324.
Jordan, K.M., et al., EULAR Recommendations 2003: an evidence based approach to the
management of knee osteoarthritis: Report of a Task Force of the Standing Committee for
International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2003.
62(12): p. 1145-55.
Langman, M.J., et al., Risks of bleeding peptic ulcer associated with individual non-steroidal
anti-inflammatory drugs. Lancet, 1994. 343(8905): p. 1075-8.
Allison, M.C., et al., Gastrointestinal damage associated with the use of nonsteroidal
antiinflammatory drugs. N Engl J Med, 1992. 327(11): p. 749-54.
Schneider, V., et al., Association of selective and conventional nonsteroidal antiinflammatory
drugs with acute renal failure: A population-based, nested case-control analysis. Am J
Epidemiol, 2006. 164(9): p. 881-9.
McGettigan, P. and D. Henry, Cardiovascular risk and inhibition of cyclooxygenase: a
systematic review of the observational studies of selective and nonselective inhibitors of
cyclooxygenase 2. Jama, 2006. 296(13): p. 1633-44.
Strom, B.L., et al., Nonsteroidal anti-inflammatory drugs and neutropenia. Arch Intern Med,
1993. 153(18): p. 2119-24.
Mockenhaupt, M., et al., The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis
associated with nonsteroidal antiinflammatory drugs: a multinational perspective. J
Rheumatol, 2003. 30(10): p. 2234-40.
Furst, D.E. and W. Anderson, Differential effects of diclofenac and aspirin on serum glutamic
oxaloacetic transaminase elevations in patients with rheumatoid arthritis and osteoarthritis.
Arthritis Rheum, 1993. 36(6): p. 804-10.
Garcia Rodriguez, L.A., et al., Acute liver injury associated with nonsteroidal anti-
inflammatory drugs and the role of risk factors. Arch Intern Med, 1994. 154(3): p. 311-6.
Kalso, E., Oxycodone. J Pain Symptom Manage, 2005. 29(5 Suppl): p. S47-56.
Fink, K., et al., Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction
of neurotransmitter release from rat neocortical slices. Br J Pharmacol, 2000. 130(4): p. 900-6.
Watson, C.P.N., M.L. Chipman, and R.C. Monks, Antidepressant analgesics: a systematic review and comparative study. 5th ed. Wall and Melzack's Textbook of pain, ed. S.B. McMahon and M. Koltzenburg2006, London: Elselvier. 481-497. Wise, T.N., D.A. Fishbain, and V. Holder-Perkins, Painful physical symptoms in depression: a
clinical challenge. Pain Med, 2007. 8 Suppl 2: p. S75-82.
Doherty, M., et al., A randomised controlled trial of ibuprofen, paracetamol or a combination
tablet of ibuprofen/paracetamol in community-derived people with knee pain. Annals of the
rheumatic diseases, 2011. 70(9): p. 1534-41.
Ballantyne, J.C. and J. Mao, Opioid therapy for chronic pain. N Engl J Med, 2003. 349(20): p.
1943-53.

Source: http://eular.ch/myUploadData/files/chapter%2048%20-%20module%2039.pdf